Elsevier

Experimental Parasitology

Volume 114, Issue 3, November 2006, Pages 204-214
Experimental Parasitology

Leishmania donovani: Intracellular ATP level regulates apoptosis-like death in luteolin induced dyskinetoplastid cells

https://doi.org/10.1016/j.exppara.2006.03.013Get rights and content

Abstract

Leishmaniasis presents a spectrum of diseases ranging from benign cutaneous lesions to the often-fatal visceralizing form. Luteolin, a dietary flavone induces apoptosis-like death in both promastigote and amastigote forms of Leishmania, the causative agent of the diseases. Here, we have elucidated the mechanism of action of luteolin by analyzing the mitochondrial and cytosolic changes associated with apoptosis-like death of leishmanial cells. In Leishmania donovani, treatment with luteolin induces the loss of both maxicircles and minicircles which resulted in the formation of dyskinetoplastid cells. The loss of mitochondrial DNA causes reduction in the activities of complex I, II, III, and IV of electron transport chain. However, the mitochondrial ATPase activity of complex V remains almost unaltered during treatment with luteolin but the sensitivity to oligomycin is lost. The inactivation of ETC complex is associated with decrease in mitochondrial as well as glycolytic ATP production, which is responsible for depolarization of Δψm and alteration in mitochondrial structure. This event is followed by the release of cytochrome c from mitochondria in mt-DNA depleted leishmanial cells and causes an activation of caspase like proteases. Collectively our results provide the first insight into the mechanistic pathway of apoptosis-like death where inhibition of glycolytic ATP production is an essential event responsible for depolarization of Δψm in mt-DNA depleted cells to propagate apoptosis-like death in leishmanial cells.

Introduction

Apoptosis is a form of programmed cell death (PCD) that is initiated and completed in an orderly manner and where purpose is to eliminate the cells without releasing their content into the extracellular environment (Green and Reed, 1998). Mitochondria are central integrating organelle in apoptosis, with the capacity to directly activate the execution pathways in both multicellular (Bossy-Wetzel and Green, 1999) and unicellular organisms like Leishmania (Debrabant et al., 2003, Das et al., 2001, Arnoult et al., 2002, Zangger et al., 2002, Sen et al., 2004). Moreover, a fall of Δψm, induced by so-called permeability transition was observed as one of the first events in the apoptotic cascade, prior to fragmentation of nuclear DNA (Scheffler, 1999, Fontaine and Bernardi, 1999). Other common factors for PCD involving mitochondria include ROS and Ca++ homeostasis and these factors were also shown to be associated with cell death (Ridgley et al., 1999).

Mitochondrial function depends on proteins that are encoded by both nuclear DNA and mitochondrial DNA (mtDNA). The mtDNA network of leishmanial cells contains two types of DNA molecules; maxicircles and minicircles (Simpson, 1986). Maxicircles encode ribosomal RNA (two ribosomal RNA genes, 9S and 12S) and several other proteins including six subunits of complex I, apocytochrome b of CoQ reductase, cytochrome c reductase (complex III), three subunits of cytochrome oxidase (complex IV), subunit A6 of ATP synthase (complex V), and a ribosomal protein (RPS 12), which are involved in the mitochondrial energy transduction. The genetic functions of the minicircles are known to encode small guide RNAs (gRNAs), which are 70 nt in size with a short oligo-U tail at the 3′ end and they govern the specificity of mRNA editing during post-transcriptional stages (Feagin, 2000).

Several flavonoid compounds have been shown to exert their action by interacting with DNA topoisomerases. The non-intercalating flavonoids like genistein and orobol and the DNA intercalating flavonoids like quercetin, myricetin and baicalein promote topoisomerase mediated site-specific DNA cleavage in mammalian cells in vitro and in vivo (Yamashita et al., 1990). From earlier studies it is known that, luteolin has both anti-inflammatory and anti-allergic properties and mediates its action by inhibiting production of nitric oxide inside cells (Kim et al., 1999). Moreover, a recent report establishes that, luteolin is a potent inhibitor of human mast cell activation and exerts its action through the inhibition of protein kinase C activation and Ca++ influx. The growth and metabolism of human leukemic cell lines like CEM-C1 and CEM-C7 are also inhibited by luteolin (Post and Varma, 1992).

From our laboratory it was previously established that luteolin is similar to camptothecin, a class I inhibitor with respect to its ability to form the topoisomerase I mediated cleavable complex Das et al. (2004). But unlike CPT, luteolin interacts with both free enzyme and substrate DNA in vitro (Chowdhury et al., 2002) and it promotes topoisomerase II mediated linearization of kDNA minicircles in vivo (Mittra et al., 2000). It inhibits the growth of L. donovani promastigotes as well as amastigotes in infected macrophages. This cytotoxic lesion causes cell cycle arrest at the G1 phase and ultimately leads to apoptosis-like death (Mittra et al., 2000). But the molecular mechanisms connecting topoisomerase II inhibition inside leishmanial cells to the activation of apoptotic machinery are still unknown and these aspects remain to be investigated for apoptotic cell death in unicellular parasite like L. donovani during treatment with a flavone like luteolin.

Previously, we have found that a non-oxidant CPT induces apoptosis-like death through generation of ROS inside cells. Endogenous toxic ROS was responsible for collapse of mitochondrial Δψm in leishmanial cells (Sen et al., 2004a). Here in the case of treatment with luteolin, oxidative stress was not generated inside leishmanial cells. This may be due to the fact that luteolin has a strong scavenging ability for peroxide radicals. So the pathway of apoptosis-like death induced by luteolin is different from signaling pathway induced by another topoisomerase I poison CPT in leishmanial cells.

Here, we have demonstrated the mechanism of luteolin induced apoptosis-like death of leishmanial cells. In the present study, we show that luteolin induces the loss of mt-DNA and resulted in the formation of dyskinetoplastid cells. These cells undergo apoptosis-like death by enhancing caspase like proteases via cytochrome c dependent pathway. Moreover, our results also provide the evidence for the involvement of glycolytic ATP to enhance the apoptotic pathway in leishmanial cells. Such information has potentially useful value in determining the role of mitochondria in apoptosis-like death of leishmanial cells and help in designing of better drugs for leishmaniasis.

Section snippets

Study of the loss of mt-DNA by confocal microscopy

Drug-treated L. donovani AG 83 promastigotes (2.5 × 106/ml) was assessed for dyskinetoplastic cells by staining with ethidium bromide (0.1 μg/ml in 1× phosphate-buffered saline containing 10% glycerol).

Study of parasite ultrastructure and mt-DNA by TEM

Transmission electron microscopy (TEM) was carried out with both luteolin treated and untreated cells as described previously (Chowdhury et al., 2002). EM of kDNA was done according to Perez-Morga and Englund (1993).

Dot-blot hybridization of nuclear and mt-DNA

Total genomic DNA was prepared from luteolin treated and untreated L. donovani cells

Treatment with luteolin causes the loss of mt-DNA (dyskinetoplastidy)

Luteolin can induce dyskinetoplastidy or loss of kinetoplast DNA (mt-DNA) in L. donovani cells after treatment for 20 h. This remarkable phenotype was visualized by staining with EtBr through confocal microscopy. As expected, when 0.2% DMSO treated control cells were stained with EtBr both nucleus (N) and a much smaller kinetoplast (K) were visualized. In contrast, after 8 h of treatment with luteolin, a small kinetoplast was detected but there is no change in the nuclei compared to control

Discussion

Polyphenols including luteolin are common components, which naturally exist in plants and have been demonstrated to show several biological properties including free radical scavenging, anti-inflammatory, and anti-carcinogenesis activities. The previous study has demonstrated that luteolin induced HL-60 cell apoptosis via topoisomerase II mediated DNA damage (Yamashita and Kawanishi, 2000). Also luteolin induces CH 27 cell apoptosis by caspase-dependent and -independent pathway and the effect

Acknowledgments

We thank Prof. S. Roy, the Director of our institute, for his interest in this work. We also acknowledge Dr. Gayatri Tripathi and Mr. Sailen Dey for their help with confocal microscopy and electron microscopy. N.S is supported by Senior Research Fellowship from the Council for Scientific and Industrial Research; Government of India.

References (43)

  • H.K. Kim et al.

    Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure–activity relationships

    Biochemical Pharmacology

    (1999)
  • M. Lahrichi et al.

    Influence of glucose and inhibitors of glycolysis on release of total proteins and enzymes from human leukocytes

    Clinica Chimica Acta

    (1977)
  • H.J. Lee et al.

    Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK

    Toxicology and Applied Pharmacology

    (2005)
  • H.W. Leung et al.

    Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosis

    European Journal Pharmacology

    (2005)
  • X. Liu et al.

    Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c

    Cell

    (1996)
  • S.B. Mukherjee et al.

    Increase in cytosolic Ca2+ levels through the activation of non-selective cation channels induced by oxidative stress causes mitochondrial depolarization leading to apoptosis-like death in Leishmania donovani promastigotes

    Journal of Biological Chemistry

    (2002)
  • L.G. Nijtmans et al.

    Expression and fate of the nuclearly encoded subunits of cytochrome-c oxidase in cultured human cells depleted of mitochondrial gene products

    Biochimica Biophysics Acta

    (1995)
  • J.F. Post et al.

    Growth inhibitory effects of bioflavonoids and related compounds on human leukemic CEM-C1 and CEM-C7 cells

    Cancer Letter

    (1992)
  • N. Sen et al.

    Camptothecin-induced imbalance in intracellular cation homeostasis regulates programmed cell death in unicellular hemoflagellate Leishmania donovani

    Journal of Biological Chemistry

    (2004)
  • G. Singh et al.

    Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani

    Molecular and Biochemical Parasitolology

    (2005)
  • D.C. Wharton et al.

    Cytochrome oxidase from beef heart mitochondria

    Methods in Enzymology

    (1967)
  • Cited by (28)

    • Apoptosis in Leishmania: biochemical footprint and its relevance to surmount leishmaniasis

      2021, Pathogenesis, Treatment and Prevention of Leishmaniasis
    • Vernonia amygdalina (Del) as an antioxidant, aspirin toxicity, and oxidative stress

      2020, Toxicology: Oxidative Stress and Dietary Antioxidants
    • Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold

      2019, European Journal of Medicinal Chemistry
      Citation Excerpt :

      Additionally, a drug targeting the mitochondrial synthesis of ATP ought to jeopardize the bioenergetic requirements of Leishmania, as 70% of them are fulfilled through oxidative phosphorylation. This assumption is in line with a growing body of evidence that underscores the effectiveness of drugs acting on the Leishmania mitochondrion [21]. In this context, we designed a new family of compounds obtained by introducing a polyamine chain at the C-4 position of the 2-styrylquinoline structure.

    • Leishmaniasis control: Limitations of current drugs and prospects of natural products

      2019, Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases
    • Activity of melatonin against Leishmania infantum promastigotes by mitochondrial dependent pathway

      2014, Chemico-Biological Interactions
      Citation Excerpt :

      This result correlates with report of induced death in Leishmania using new Benzophenone-Derived Bisphosphonium Salts, which inhibit complex II [107]. Several studies have described complex III as an attractive target for antiprotozoal drugs [106]. Tafenoquine was found to cause a mitochondrial dysfunction in Leishmania by complex III (cytochrome c reductase) inhibition [19].

    • Natural product based leads to fight against leishmaniasis

      2014, Bioorganic and Medicinal Chemistry
    View all citing articles on Scopus
    View full text